|
1.
|
総説
|
（１）グルココルチコイドの代謝への影響 -脂肪組織グルココルチコイド受容体の機能解析-．生理活性物質の新知見． 2024
|
|
2.
|
総説
|
Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient. 2023/12/13
|
|
3.
|
症例報告
|
A Rare Case of Placental Abruption and Postpartum Compression Fractures in Pregnancy with Cushing Syndrome. 2023/11/16
|
|
4.
|
原著
|
HSP47 levels determine the degree of body adiposity. 2023/11/11
|
|
5.
|
総説
|
下垂体疾患の診断と治療の手引きについて 2023/07/01
|
|
6.
|
総説
|
免疫チェックポイント阻害薬による内分泌障害 2023/02/28
|
|
7.
|
総説
|
無月経と高プロラクチン血症．下垂体②．日常臨床にひそむ内分泌疾患と最近の話題（III）．KYORIN -Symposia． 2023
|
|
8.
|
原著
|
Favine/CCDC3 deficiency accelerated atherosclerosis and thrombus formation is associated with decreased MEF2C-KLF2 pathway. 2022/11
|
|
9.
|
原著
|
Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism. 2022/09
|
|
10.
|
原著
|
ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors. 2022/08
|
|
11.
|
原著
|
Ketone body 3-hydroxybutyrate enhances adipocyte function. 2022/06
|
|
12.
|
原著
|
Lactate dehydrogenase regulates basal glucose uptake in adipocytes. 2022/06
|
|
13.
|
原著
|
Plasma NfL is associated with mild cognitive decline in patients with diabetes. 2022/05
|
|
14.
|
総説
|
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. 2022/04
|
|
15.
|
原著
|
Transforming growth factor β1 signaling links extracellular matrix remodeling to intracellular lipogenesis upon physiological feeding events. 2022/04
|
|
16.
|
原著
|
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision) 2022
|
|
17.
|
原著
|
Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess. 2022
|
|
18.
|
総説
|
序文．総説企画：内分泌疾患と肥満 2022
|
|
19.
|
総説
|
成人成長ホルモン分泌不全症と肥満 2022
|
|
20.
|
総説
|
閉経後の高プロラクチン血症に対する治療の必要性 2022
|
|
21.
|
原著
|
Glutamine deficiency induces lipolysis in adipocytes. 2021/12/31
|
|
22.
|
総説
|
Cushing病． 2021/12/22
|
|
23.
|
総説
|
下垂体前葉機能低下症． 2021/12
|
|
24.
|
原著
|
Increased Dosage of MRA Improves BP and Urinary Albumin Excretion in Primary Aldosteronism With Suppressed Plasma Renin. 2021/11/19
|
|
25.
|
原著
|
γENaC/CD9 in urinary extracellular vesicles as a potential biomarker of MR activity 2021/11/01
|
|
26.
|
総説
|
原発性副腎皮質機能低下症 2021/10/15
|
|
27.
|
原著
|
Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With Coronavirus SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19 2021/10/06
|
|
28.
|
症例報告
|
A Japanese patient with a 2p25.3 terminal deletion presented with early-onset obesity, intellectual disability and diabetes mellitus: A case report 2021/08/11
|
|
29.
|
総説
|
TSH産生腫瘍 2021/08
|
|
30.
|
症例報告
|
Laparoscopic resection of aortocaval paraganglioma diagnosed by serial increase in urinary metanephrines after bilateral adrenalectomy in a patient with multiple endocrine neoplasia type 2A 2021/06/04
|
|
31.
|
原著
|
Diverse pathological lesions of primary aldosteronism and their clinical significance 2021/05
|
|
32.
|
症例報告
|
Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report 2021/04
|
|
33.
|
原著
|
Association of abdominal obesity with crossing capillaries in the finger nailfold in type 2 diabetes mellitus 2021
|
|
34.
|
原著
|
Characteristics of non-functioning pituitary adenomas that cause secondary adrenal insufficiency 2021
|
|
35.
|
症例報告
|
Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism 2021
|
|
36.
|
原著
|
Association of crossing capillaries in the finger nailfold with diabetic retinopathy in type 2 diabetes mellitus 2020
|
|
37.
|
原著
|
Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism 2020
|
|
38.
|
原著
|
Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism 2020
|
|
39.
|
症例報告
|
Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of FGFR1 2020
|
|
40.
|
原著
|
Metabolomic Analysis of Diet-Induced Obese Mice Supplemented with Eicosapentaenoic Acid 2020
|
|
41.
|
原著
|
Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism 2020
|
|
42.
|
症例報告
|
Oral Contraceptive Disturbedthe Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome: A Case Report 2020
|
|
43.
|
原著
|
Renal function is associated with blood neurofilament light chain level in older adults 2020
|
|
44.
|
総説
|
原発性アルドステロン症の予後の最新知見． 2020
|
|
45.
|
原著
|
Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. 2019/05
|
|
46.
|
原著
|
Adipocyte GR Inhibits Healthy Adipose Expansion Through Multiple Mechanisms in Cushing Syndrome 2019
|
|
47.
|
症例報告
|
Asymptomatic Pontine Lesion and Diabetic Amyotrophy after Rapid Improvement of Poor Glycemic Control in a Patient with Type 1 Diabetes 2019
|
|
48.
|
原著
|
Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism 2019
|
|
49.
|
原著
|
Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load 2019
|
|
50.
|
原著
|
Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency 2019
|
|
51.
|
原著
|
High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan 2019
|
|
52.
|
原著
|
Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan 2019
|
|
53.
|
原著
|
Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling 2019
|
|
54.
|
原著
|
Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism 2019
|
|
55.
|
総説
|
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society 2019
|
|
56.
|
症例報告
|
Marked Hypergastrinemia with G-cell Hyperplasia in Two Autoimmune Gastritis Patients 2019
|
|
57.
|
原著
|
Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes 2019
|
|
58.
|
症例報告
|
Rare case of Leydig cell tumor with type I diabetes mellitus causing female pattern hair loss 2019
|
|
59.
|
原著
|
The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism 2019
|
|
60.
|
総説
|
下垂体機能低下症． 2019
|
|
61.
|
総説
|
倦怠感． 2019
|
|
62.
|
総説
|
免疫チェックポイント阻害薬による内分泌機能障害． 2019
|
|
63.
|
症例報告
|
A case of monoclonal gammopathy of undetermined significance with abnormal low levels of plasma glycated albumin by M protein. 2018/12
|
|
64.
|
原著
|
Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly. 2018/10
|
|
65.
|
原著
|
Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism. 2018/08
|
|
66.
|
原著
|
Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism 2018
|
|
67.
|
原著
|
Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross-sectional study 2018
|
|
68.
|
総説
|
Cushing症候群・副腎性subclinical Cushing症候群の診断と治療 2018
|
|
69.
|
原著
|
Evaluation of Hypothalamic–Pituitary–Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test 2018
|
|
70.
|
原著
|
Impact of MR on mature adipocytes in high-fat/high-sucrose diet-induced obesity 2018
|
|
71.
|
原著
|
Metabolomic and microarray analyses of adipose tissue of dapagliflozin-treated mice, and effects of 3-hydroxybutyrate on induction of adiponectin in adipocytes 2018
|
|
72.
|
総説
|
New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society 2018
|
|
73.
|
原著
|
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism 2018
|
|
74.
|
原著
|
Oxidative Stress Inhibits Healthy Adipose Expansion Through Suppression of SREBF1-Mediated Lipogenic Pathway 2018
|
|
75.
|
原著
|
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan 2018
|
|
76.
|
原著
|
SDF-1 Is an Autocrine Insulin-Desensitizing Factor in Adipocytes 2018
|
|
77.
|
原著
|
Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism 2018
|
|
78.
|
症例報告
|
Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy 2018
|
|
79.
|
原著
|
TSH ratio as a novel diagnostic method for Cushing's syndrome 2018
|
|
80.
|
総説
|
偽性Cushing症候群． 2018
|
|
81.
|
総説
|
副腎皮質機能低下症． 2018
|
|
82.
|
症例報告
|
両側副腎摘除を必要とした難治性クッシング病の1例 2018
|
|
83.
|
原著
|
プロラクチノーマに対する薬物治療中止の目安と時期は? 2017/10
|
|
84.
|
原著
|
Eicosapentaenoic acid and 5-HEPE enhance macrophage-mediated Treg induction in mice 2017
|
|
85.
|
症例報告
|
Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient 2017
|
|
86.
|
原著
|
Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism 2017
|
|
87.
|
原著
|
Regulation of Dipeptidyl Peptidase-4, its Substrate Chemokines, and Their Receptors in Adipose Tissue of ob/ob Mice 2017
|
|
88.
|
原著
|
Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism 2017
|
|
89.
|
その他
|
副腎不全を疑う時は? 2017
|
|
90.
|
症例報告
|
A case of glucocorticoid-induced diabetes in which the efficacy between sitagliptin and metformin was compared 2016
|
|
91.
|
原著
|
Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan 2016
|
|
92.
|
原著
|
Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors 2016
|
|
93.
|
総説
|
Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion] 2016
|
|
94.
|
原著
|
Identification of Mouse Mesenteric and Subcutaneous in vitro Adipogenic Cells 2016
|
|
95.
|
原著
|
Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome 2016
|
|
96.
|
原著
|
Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease 2016
|
|
97.
|
原著
|
Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients 2016
|
|
98.
|
症例報告
|
Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist 2016
|
|
99.
|
原著
|
Adipose tissue macrophages induce PPARgamma-high FOXP3(+) regulatory T cells 2015
|
|
100.
|
原著
|
Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome 2015
|
|
101.
|
症例報告
|
Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis 2015
|
|
102.
|
原著
|
Effects of growth hormone excess on glycated albumin concentrations: Analysis in acromegalic patients 2015
|
|
103.
|
原著
|
Fat/vessel-derived secretory protein (Favine)/CCDC3 is involved in lipid accumulation 2015
|
|
104.
|
原著
|
Postoperative changes in bone metabolism and bone mineral density in Japanese patients with acromegaly: a 3-year prospective study 2015
|
|
105.
|
総説
|
治療（糖質コルチコイド補充療法） 過剰糖質コルチコイド(GC)補充療法の弊害． 2015
|
|
106.
|
症例報告
|
Aniridia with a heterozygous PAX6 mutation in which the pituitary function was partially impaired 2014
|
|
107.
|
原著
|
Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response 2014
|
|
108.
|
原著
|
Rapid decline in bone turnover markers but not bone mineral density in acromegalic patients after transsphenoidal surgery 2014
|
|
109.
|
原著
|
Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome 2014
|
|
110.
|
原著
|
Sitagliptin Significantly Decreases the Ratio of Glycated Albumin to HbA1c in Patients with Type 2 Diabetes Mellitus 2014
|
|
111.
|
症例報告
|
A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves'Disease with Methimazole 2013
|
|
112.
|
原著
|
Adiponectin regulates vascular endothelial growth factor-C expression in macrophages via Syk-ERK pathway 2013
|
|
113.
|
原著
|
Association of subclinical hypothalamic-pituitary-adrenal axis suppression with bone loss in patients with asthma taking inhaled corticosteroids 2013
|
|
114.
|
原著
|
Dipeptidyl peptidase-4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin-secreting capacity, a higher body mass index and insulin resistance 2013
|
|
115.
|
症例報告
|
Exenatide alters absorption of hydrocortisone in a diabetic patient with panhypopituitarism: iatrogenic adrenal insufficiency 2013
|
|
116.
|
原著
|
Expression of activating transcription factor 2 in inflammatory macrophages in obese adipose tissue 2013
|
|
117.
|
原著
|
Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome 2013
|
|
118.
|
原著
|
Hyperthyroidism due to thyroid-stimulating hormone secretion after surgery for Cushing's syndrome: a novel cause of the syndrome of inappropriate secretion of thyroid-stimulating hormone 2013
|
|
119.
|
症例報告
|
Juxtaglomerular cell tumor that was preoperatively diagnosed using selective renal venous sampling 2013
|
|
120.
|
原著
|
Obstructive sleep apnea syndrome causes a pseudo-Cushing's state in Japanese obese patients with type 2 diabetes mellitus 2013
|
|
121.
|
症例報告
|
Pseudohypoglycemia or hyperglycemia caused by interference with self-monitoring blood glucose measurements in anticancer ascorbic acid therapy 2013
|
|
122.
|
症例報告
|
Serum vitamin D levels are decreased in patients without remission of Graves'disease 2013
|
|
123.
|
原著
|
Study on the mechanism causing elevation of serum CA19-9 levels in diabetic patients 2013
|
|
124.
|
原著
|
The temporary drop of serum octreotide concentration deteriorated ventricular tachycardia in an acromegalic patient 2013
|
|
125.
|
原著
|
Tocilizumab for the treatment of patients with refractory Takayasu arteritis. 2013
|
|
126.
|
総説
|
下垂体前葉機能低下症． 2013
|
|
127.
|
原著
|
オクトレオチドLAR治療が先端巨大症患者のQOL・臨床症状に与える影響． 2012/08
|
|
128.
|
症例報告
|
A case of hypogonadotropic hypogonadism caused by opioid treatment for nonmalignant chronic pain 2012
|
|
129.
|
症例報告
|
A case of long-standing autoimmune type 1 diabetes with common variable immunodeficiency 2012
|
|
130.
|
原著
|
Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone 2012
|
|
131.
|
症例報告
|
Large adrenal ganglioneuroma 2012
|
|
132.
|
症例報告
|
Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves'disease 2012
|
|
133.
|
症例報告
|
Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol 2012
|
|
134.
|
総説
|
ステロイドホルモンと脂質代謝-基礎と臨床 オーバービュー- 2012
|
|
135.
|
総説
|
内分泌疾患による糖尿病 先端巨大症． 2012
|
|
136.
|
原著
|
Association of urine acidification with visceral obesity and the metabolic syndrome 2011
|
|
137.
|
原著
|
Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathy 2011
|
|
138.
|
症例報告
|
Right-sided acute suppurative thyroiditis caused by infectious endocarditis 2011
|
|
139.
|
総説
|
インスリン抵抗性のナゾをとく！インスリン抵抗性がある患者さんへはどう指導・処方するの？ 2011
|
|
140.
|
原著
|
吸入ステロイド薬継続投与中の閉経後喘息患者における骨密度および骨代謝マーカーの検討-骨粗鬆症治療群と非治療群の比較-． 2011
|
|
141.
|
原著
|
Characteristics of sleep-disordered breathing in Japanese patients with type 2 diabetes mellitus 2010
|
|
142.
|
原著
|
Identification of a new secretory factor, CCDC3/Favine, in adipocytes and endothelial cells 2010
|
|
143.
|
原著
|
Measurement of adiponectin production from differentiated metabolic stem cells 2010
|
|
144.
|
原著
|
Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids 2010
|
|
145.
|
原著
|
グリメピリド長期投与2型糖尿病患者の臨床的特徴 2009/08
|
|
146.
|
原著
|
尿酸性化が内臓肥満およびメタボリックシンドローム関連指標に及ぼす影響 2009/05
|
|
147.
|
原著
|
Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients 2009
|
|
148.
|
原著
|
Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels 2009
|
|
149.
|
原著
|
Effects of estrogen on gene expression profiles in mouse hypothalamus and white adipose tissue: target genes include glutathione peroxidase 3 and cell death-inducing DNA fragmentation factor, alpha-subunit-like effector A 2008
|
|
150.
|
症例報告
|
Painless thyroiditis occurring during post-menopausal period, following remission of Graves'disease 2008
|
|
151.
|
総説
|
その他の調節因子 ソマトスタチン． 2008
|
|
152.
|
総説
|
エストロゲンとメタボリックシンドローム． 2008
|
|
153.
|
総説
|
副腎ホルモン補充療法 補充療法に用いられる合成ステロイドホルモン． 2008
|
|
154.
|
原著
|
Independent association between insulin-like growth factor-I and dehydroepiandrosterone sulphate in women in middle adulthood 2007
|
|
155.
|
原著
|
Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women 2007
|
|
156.
|
原著
|
Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels 2007
|
|
157.
|
原著
|
Reduced epinephrine reserve in response to insulin-induced hypoglycemia in patients with pituitary adenoma 2007
|
|
158.
|
原著
|
Atherosclerotic risk factors in Japanese subjects with isolated impaired fasting glucose and those with isolated impaired glucose tolerance according to 1997 and 2003 American Diabetes Association criteria 2006
|
|
159.
|
原著
|
The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells 2006
|
|
160.
|
原著
|
Regeneration of tubular complex is promoted by a free space 2005
|
|
161.
|
原著
|
Sex differences of age-dependent changes of insulin sensitivity in Japanese nondiabetic subjects 2005
|
|
162.
|
総説
|
Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus 2005
|
|
163.
|
原著
|
Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue 2004
|
|
164.
|
原著
|
Identification of a functional variant of estrogen receptor beta in an African population 2004
|
|
165.
|
総説
|
Cardiovascular roles of estrogen receptors: insights gained from knockout models 2003
|
|
166.
|
原著
|
Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus 2003
|
|
167.
|
原著
|
Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications 2003
|
|
168.
|
原著
|
Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta 2003
|
|
169.
|
症例報告
|
Impaired counter-regulation to hypoglycemia in a patient with stress. 2002
|
|
170.
|
原著
|
RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells 2002
|
|
171.
|
原著
|
Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. 2001/06
|
|
172.
|
原著
|
Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence 2001
|
|
173.
|
原著
|
PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells 2001
|
|
174.
|
原著
|
Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells 2001
|
|
175.
|
原著
|
【ステロイドホルモン研究の進歩】アンドロゲン,他 プロゲステロンによる血管内皮細胞のVCAM-1発現抑制の分子機構 2000/11
|
|
176.
|
原著
|
Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients 2000
|
|
177.
|
原著
|
【ステロイドホルモン研究の進歩1999】エストロゲン エストロゲン応答 血管内皮細胞におけるVCAM-1発現に対するエストロゲン類似化合物の作用 1999/10
|
|
178.
|
原著
|
Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus 1998
|
|
179.
|
症例報告
|
A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide 1997
|
|
180.
|
原著
|
Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients 1997
|
|
181.
|
原著
|
糖尿病患者における血中 soluble VCAM-1測定の臨床的意義－動脈硬化症との関連について－ 1997
|
|
182.
|
原著
|
末梢型肺扁平上皮癌の気管浸潤にCDDP動注と放射線療法が奏効した1症例 1996/12
|
|
5件表示
|
|
全件表示(182件)
|
